Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Condition affects an estimated 446,500 people in the country and is the underlying cause for nearly one in 10 deaths ...
STOCKHOLM, Sept. 24, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi) ...
Globally recognised Alzheimer's researcher Professor Ralph Martins AO has been appointed the inaugural Chair of Alzheimer's ...
Dementia Training Australia has received $22 million in Commonwealth funding to build a dementia-capable workforce while the ...
Hosted on MSN
Alzheimer's drug Lecanemab approved by Therapeutic Goods Administration for use in Australia
A promising new Alzheimer's drug has been green-lit by the national medicines regulator, after two previous failed attempts to register it for use in Australia. Lecanemab, sold under the brand name ...
The actor, who inherited a high-risk gene for Alzheimer’s disease, explores ways to potentially slow down the disease.
Adelaide community members tied up their laces and showed up in force last weekend for the 2026 Adelaide Memory Walk & Jog - throwing their support ...
TOKYO and CAMBRIDGE, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (BIIB) (Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results